Clinical significance of mitochondrial glutamic-oxaloacetic transaminase in serum of patients with liver disease. 1978

S Okuyama, and Y Kato, and A Funayama, and A Kusakabe, and T Hara, and T Yamawaki, and S Kurokawa, and T Inagaki, and S Ito, and N Sakamoto

Serum mitochondrial glutamic-oxaloacetic transaminase activity was determined in 83 patients with various liver diseases and 10 healthy adults. 1) The average of mitochondrial glutamic-oxaloacetic transaminase value was 1.2 mU in healthy adults, 8.3 mU in patients with acute hepatitis, 13.7 mU in patients with post-transfusion hepatitis, 5.0 mU in patients with persistent hepatitis, 4.5 mU in patients with chronic inactive hepatitis, 9.6 mU in patients with chronic active hepatitis, 5.6 mU in liver cirrhosis, and 295 mU in a patient with fulminant hepatitis. 2) While one patient with acute hepatitis showed the highest value in the group of 29 mU, one patient with fulminant hepatitis showed an extremely high value of 295 mU, revealing an obvious difference between them. 3) One patient with fresh myocardial infarction also showed an extremely high value of 110 mU.

UI MeSH Term Description Entries
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D006505 Hepatitis INFLAMMATION of the LIVER. Hepatitides
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D001219 Aspartate Aminotransferases Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1. Aspartate Aminotransferase,Aspartate Transaminase,Glutamic-Oxaloacetic Transaminase,SGOT,Aspartate Apoaminotransferase,Glutamate-Aspartate Transaminase,L-Aspartate-2-Oxoglutarate Aminotransferase,Serum Glutamic-Oxaloacetic Transaminase,Aminotransferase, Aspartate,Aminotransferase, L-Aspartate-2-Oxoglutarate,Aminotransferases, Aspartate,Apoaminotransferase, Aspartate,Glutamate Aspartate Transaminase,Glutamic Oxaloacetic Transaminase,Glutamic-Oxaloacetic Transaminase, Serum,L Aspartate 2 Oxoglutarate Aminotransferase,Serum Glutamic Oxaloacetic Transaminase,Transaminase, Aspartate,Transaminase, Glutamate-Aspartate,Transaminase, Glutamic-Oxaloacetic,Transaminase, Serum Glutamic-Oxaloacetic

Related Publications

S Okuyama, and Y Kato, and A Funayama, and A Kusakabe, and T Hara, and T Yamawaki, and S Kurokawa, and T Inagaki, and S Ito, and N Sakamoto
May 1979, [Hokkaido igaku zasshi] The Hokkaido journal of medical science,
S Okuyama, and Y Kato, and A Funayama, and A Kusakabe, and T Hara, and T Yamawaki, and S Kurokawa, and T Inagaki, and S Ito, and N Sakamoto
April 1960, Indian journal of medical sciences,
S Okuyama, and Y Kato, and A Funayama, and A Kusakabe, and T Hara, and T Yamawaki, and S Kurokawa, and T Inagaki, and S Ito, and N Sakamoto
June 1959, Canadian Medical Association journal,
S Okuyama, and Y Kato, and A Funayama, and A Kusakabe, and T Hara, and T Yamawaki, and S Kurokawa, and T Inagaki, and S Ito, and N Sakamoto
February 1988, Nihon juigaku zasshi. The Japanese journal of veterinary science,
S Okuyama, and Y Kato, and A Funayama, and A Kusakabe, and T Hara, and T Yamawaki, and S Kurokawa, and T Inagaki, and S Ito, and N Sakamoto
December 1956, Canadian Medical Association journal,
S Okuyama, and Y Kato, and A Funayama, and A Kusakabe, and T Hara, and T Yamawaki, and S Kurokawa, and T Inagaki, and S Ito, and N Sakamoto
October 1973, The Journal of the Association of Physicians of India,
S Okuyama, and Y Kato, and A Funayama, and A Kusakabe, and T Hara, and T Yamawaki, and S Kurokawa, and T Inagaki, and S Ito, and N Sakamoto
February 1978, Clinica chimica acta; international journal of clinical chemistry,
S Okuyama, and Y Kato, and A Funayama, and A Kusakabe, and T Hara, and T Yamawaki, and S Kurokawa, and T Inagaki, and S Ito, and N Sakamoto
March 1957, The Journal of the Tennessee State Medical Association. Tennessee State Medical Association,
S Okuyama, and Y Kato, and A Funayama, and A Kusakabe, and T Hara, and T Yamawaki, and S Kurokawa, and T Inagaki, and S Ito, and N Sakamoto
March 1956, Transactions of the New York Academy of Sciences,
S Okuyama, and Y Kato, and A Funayama, and A Kusakabe, and T Hara, and T Yamawaki, and S Kurokawa, and T Inagaki, and S Ito, and N Sakamoto
March 1958, British medical journal,
Copied contents to your clipboard!